Видео ютуба по тегу Protein Kinase Inhibitors

Tyrosine Kinase Inhibitors (TKIs) - Imatinib (Gleevec) - Pharmacology - CML and ALL
Tyrosine Kinase Inhibitors (TKIs) - Imatinib (Gleevec) - Pharmacology - CML and ALL
Human Protein Kinase CK2 Inhibitors: Discovering New Scaffolds
Human Protein Kinase CK2 Inhibitors: Discovering New Scaffolds
Bruton Tyrosine Kinase Inhibitors
Bruton Tyrosine Kinase Inhibitors
HCC Whiteboard #2: The Mechanisms of Action of Tyrosine Kinase Inhibitors
HCC Whiteboard #2: The Mechanisms of Action of Tyrosine Kinase Inhibitors
Pharmacology - CANCER DRUGS – CELL CYCLE INHIBITORS (MADE EASY)
Pharmacology - CANCER DRUGS – CELL CYCLE INHIBITORS (MADE EASY)
HCC Whiteboard #3: The Management of Adverse Events of Tyrosine Kinase Inhibitors
HCC Whiteboard #3: The Management of Adverse Events of Tyrosine Kinase Inhibitors
Newer Cancer Treatment Updates 2025 - 06 March
Newer Cancer Treatment Updates 2025 - 06 March
For physicians: VEGF tyrosine kinase inhibitor treatment risks | Dana-Farber Cancer Institute
For physicians: VEGF tyrosine kinase inhibitor treatment risks | Dana-Farber Cancer Institute
06 - Kinases and their Role in Cancer - Interview with Dr. Jing Chen
06 - Kinases and their Role in Cancer - Interview with Dr. Jing Chen
Dr. Grigg on Frontline Tyrosine Kinase Inhibitors in RCC
Dr. Grigg on Frontline Tyrosine Kinase Inhibitors in RCC
Tyrosine kinase inhibitors by DAMS Faculty
Tyrosine kinase inhibitors by DAMS Faculty
Highlights From Bruton’s Tyrosine Kinase Inhibitors
Highlights From Bruton’s Tyrosine Kinase Inhibitors
Use of VEGF-Targeted Tyrosine Kinase Inhibitors
Use of VEGF-Targeted Tyrosine Kinase Inhibitors
Update on the efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukemia
Update on the efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukemia
Inhibition of ABL tyrosine kinases shows potential for metastatic cancer treatment
Inhibition of ABL tyrosine kinases shows potential for metastatic cancer treatment
The future of tyrosine kinase inhibitors for melanoma and open questions
The future of tyrosine kinase inhibitors for melanoma and open questions
Immuno-oncology agents plus tyrosine kinase inhibitors?
Immuno-oncology agents plus tyrosine kinase inhibitors?
Substrate Targeting by Protein Kinases
Substrate Targeting by Protein Kinases